---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-005011"
form_type: "8-K"
ticker: "MCRB"
cik: "0001609809"
company_name: "Seres Therapeutics, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T19:28:49.532043+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Seres Therapeutics posts updated corporate presentation for JPMorgan conference without new material data

## Summary
- Company posted updated corporate presentation on investor website ahead of J.P. Morgan Conference on January 16, 2025.
- Presentation contains no new financial guidance, clinical data, or material operational milestones.
- No material changes from previously disclosed results or pipeline status are indicated.

## SEC filing metadata
- accession: 0001193125-25-005011
- form_type: 8-K
- ticker: MCRB
- cik: 0001609809
- company_name: Seres Therapeutics, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609809/000119312525005011/0001193125-25-005011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609809/000119312525005011/d923845d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-005011
- JSON: https://secwatch.observer/filing/0001193125-25-005011.json
- Plain text: https://secwatch.observer/filing/0001193125-25-005011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.